Clinical trials of ibuprofen in Japan. Report from the Drug Evaluation Committee, the official organ of the Japan Rheumatism Association.
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D001593:Benzyl Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D001835:Body Weight; D005260:Female; D006454:Hemoglobins; D006801:Humans; D007564:Japan; D007958:Leukocyte Count; D008297:Male; D008722:Methods; D008875:Middle Aged; D011422:Propionates / Q000627:therapeutic use; D012877:Skin Manifestations; D013223:Statistics as Topic; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D001593:Benzyl Compounds; D006454:Hemoglobins; D011422:Propionates; D000469:Alkaline Phosphatase; D001241:Aspirin